Get Your Personalized Supplement StackSupplement Stack Quiz

Novasoy Isoflavone Concentrate

Also known as: Novasoy Isoflavone Concentrate, Soy phytoestrogens, Novasoy concentrate, Genistein, Daidzein, Glycitein, Soy Isoflavones

Overview

Novasoy Isoflavone Concentrate is a proprietary extract derived from soybeans (*Glycine max*), standardized for its content of isoflavones, which are a class of plant-derived compounds known as phytoestrogens. The primary isoflavones include genistein, daidzein, and glycitein. These compounds exhibit estrogen-like activity in the body, primarily by selectively binding to estrogen receptors, particularly ER-beta. This supplement is predominantly used to alleviate common menopausal symptoms, such as hot flashes, and is also investigated for its potential benefits in supporting cardiovascular health and improving metabolic parameters. Research on soy isoflavones is extensive, with numerous randomized controlled trials and meta-analyses supporting their efficacy, especially in managing menopausal symptoms. It is categorized as a phytoestrogen dietary supplement and botanical extract.

Benefits

Soy isoflavones, including Novasoy, offer several evidence-based benefits, primarily for perimenopausal and postmenopausal women. The most significant benefit is the reduction of menopausal symptoms, particularly hot flashes. Meta-analyses of multiple randomized controlled trials (RCTs) consistently show that soy isoflavones can reduce hot flash frequency by approximately 20-26% compared to placebo, a clinically meaningful effect. This benefit typically manifests within 6 weeks to 12 months of consistent supplementation. Beyond menopausal relief, soy isoflavones may contribute to cardiovascular health by reducing blood pressure; a meta-analysis of 11 RCTs indicated a reduction of about 5.9 mmHg in systolic and 3.3 mmHg in diastolic blood pressure in hypertensive subjects. Furthermore, in menopausal women, soy isoflavones have been shown to improve metabolic parameters, significantly reducing fasting blood glucose and insulin levels, suggesting better glycemic control. While potential improvements in skin health and arterial function have been suggested, these require further robust validation.

How it works

Soy isoflavones function as selective estrogen receptor modulators (SERMs). Their primary mechanism involves binding to estrogen receptors (ERs), particularly estrogen receptor beta (ERβ), with higher affinity than to ER alpha (ERα). This preferential binding allows them to exert estrogenic or anti-estrogenic effects depending on the tissue and the body's endogenous estrogen levels. In the context of menopausal symptoms, isoflavones are believed to modulate the hypothalamic thermoregulatory center, thereby reducing the frequency and severity of vasomotor symptoms like hot flashes. They also influence endothelial function in blood vessels, contributing to cardiovascular benefits. After absorption in the gut, isoflavones are metabolized by intestinal bacteria into more active forms, such as equol, which can influence individual response variability.

Side effects

Soy isoflavones are generally considered safe and well-tolerated when consumed at recommended dosages, typically up to 100-200 mg/day. Common side effects, reported in some trials but not significantly more frequently than with placebo, include mild gastrointestinal symptoms such as nausea and diarrhea, breast tenderness, heartburn, and occasional rash. These effects are usually mild and transient. Uncommon or rare severe adverse events have not been consistently reported in high-quality randomized controlled trials. Regarding drug interactions, no major interactions have been definitively documented. However, caution is advised for individuals with hormone-sensitive conditions or those undergoing concurrent estrogen therapy due to the phytoestrogenic nature of isoflavones. Contraindications include known soy allergy. Individuals with a history of hormone-dependent cancers should consult a healthcare provider before use, as more evidence is needed to fully assess safety in this population. Safety in pregnant or breastfeeding women has not been established, and therefore, use is not recommended.

Dosage

For menopausal symptom relief, the minimum effective dose of soy isoflavones is approximately 50 mg/day (aglycone equivalents). The optimal dosage range commonly studied and found effective is between 50-100 mg/day. Some studies have utilized doses up to 200 mg/day without reporting an increase in adverse effects, suggesting this as a potential maximum safe dose for short to medium-term use. Dosing should be daily, and benefits typically become noticeable after at least 6 weeks of consistent supplementation, with continued improvement over several months. It is important to use standardized soy isoflavone concentrates, such as Novasoy, to ensure a consistent and accurate isoflavone content. Individual responses can vary due to factors like gut microbiota composition, which influences the metabolism and bioavailability of isoflavones, particularly the production of equol. No specific cofactors are required for efficacy, but a generally healthy diet is always recommended.

FAQs

Is Novasoy effective for hot flashes?

Yes, multiple meta-analyses and clinical trials support that soy isoflavones, including Novasoy, significantly reduce the frequency and severity of menopausal hot flashes.

Is it safe for long-term use?

Current evidence supports the safety of soy isoflavones for up to 12 months of continuous use. Longer-term safety data are more limited, and consultation with a healthcare provider is recommended for extended use.

Can it be used with hormone replacement therapy?

Caution is advised when combining soy isoflavones with hormone replacement therapy due to potential additive estrogenic effects. It is crucial to consult a healthcare provider before concurrent use.

When do effects appear?

Benefits, particularly for hot flashes, typically begin to appear within 6 weeks of consistent daily supplementation, with more pronounced effects often observed after several months.

Are there differences between natural and synthetic isoflavones?

Both natural extracts and synthetic forms appear effective. Novasoy is a natural soy extract standardized for its isoflavone content, ensuring consistency.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/22433977/ – This systematic review and meta-analysis of 19 randomized controlled trials found that soy isoflavones significantly reduced hot flash frequency by approximately 20.6% compared to placebo in perimenopausal and postmenopausal women, with benefits observed over 6 weeks to 12 months. The study highlights the efficacy of isoflavones in managing menopausal vasomotor symptoms.
https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Soy-isoflavones-Cognitive-Vitality-For-Researchers.pdf – This meta-analysis, which included 11-17 RCTs, investigated the cardiovascular and metabolic effects of soy isoflavones in menopausal women. It reported reductions in systolic blood pressure by about 5.9 mmHg and improvements in fasting glucose and insulin levels, suggesting potential benefits for cardiovascular health and glycemic control.
https://www.adm.com/globalassets/products--services/human-nutrition/products/specialty-health-solutions/19adn008_novasoyisoflavones_refresh_031220.pdf – This document, likely a product information sheet or review, mentions a pilot RCT using Novasoy with 128 women over approximately two months. It noted good adherence and reported that side effects were mild and similar to placebo, with no significant adverse effects, supporting the general safety profile of Novasoy.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3723773/ – This article discusses the role of phytoestrogens, including soy isoflavones, as selective estrogen receptor modulators (SERMs). It explains their mechanism of action, particularly their preferential binding to ER-beta, which contributes to their therapeutic effects in conditions like menopausal symptoms and their potential impact on various body systems.
https://experts.llu.edu/en/publications/extracted-or-synthesized-soybean-isoflavones-reduce-menopausal-ho-2 – This publication likely discusses the efficacy of both extracted and synthesized soybean isoflavones in reducing menopausal hot flashes. It reinforces the understanding that different forms of isoflavones can be effective, and highlights the importance of standardized products like Novasoy for consistent results.